Association between urinary molybdenum levels^a and systemic levels of oxidative stress and inflammation. by Joo Hong Joun (19287602)

Association between urinary molybdenum levels^a and various kidney disease-related parameters. by Joo Hong Joun (19287602)

Generalized linear mixed-effects model (GLMM) results for adult female northern fur seal estimated behavioral state. by Noel A. Pelland (550209)

Table_1_Associations between maternal urinary kisspeptin in late pregnancy and decreased fetal growth: a pregnancy-birth cohort study.docx by Jiaxian Chen (9466099)

Peak stress decreases following a ramp-stretch as the time of stretch (post-load clamp) increases, consistent with the twitch relaxation throughout diastole. by Bertrand C. W. Tanner (18098420)

“…B) An example of peak stress decreasing from multiple time points as time-to-stretch increased; same trabecula as in panel A. …”

Linear relationship between ontogeny (using skull length as a proxy) and the averaged degree of sutural closure in <i>A</i>. <i>mississippiensis</i> (n = 46). by Alida M. Bailleul (167500)

Linear discriminant analysis effect size (LEfSe) of gut microbiota in sand flies and <i>Culex nigripalpus</i> de Colombia. by Rafael J. Vivero-Gomez (11859151)

ClOO• determination using TMB (a, b) and DPPH (c,d) method. by Hiroyuki Kawata (4002656)

An ATR-specific inhibitor decreases HBoV1 infection of HAE-ALI. by Xuefeng Deng (138723)

An ATM-specific inhibitor decreases HBoV1 infection of HAE-ALI. by Xuefeng Deng (138723)

Ln(Mean number of agents—2.2) versus AIB, black points with standard deviation are data and red is a linear fit. by G. Jordan Maclay (11714526)

Table_2_Elevated triglyceride-glucose index associated with increased risk of diabetes in non-obese young adults: a longitudinal retrospective cohort study from multiple Asian coun... by Jian Han (211805)

“…A non-linear relationship was observed with an inflection point at 7.3. …”

Table_3_Elevated triglyceride-glucose index associated with increased risk of diabetes in non-obese young adults: a longitudinal retrospective cohort study from multiple Asian coun... by Jian Han (211805)

“…A non-linear relationship was observed with an inflection point at 7.3. …”

Table_1_Elevated triglyceride-glucose index associated with increased risk of diabetes in non-obese young adults: a longitudinal retrospective cohort study from multiple Asian coun... by Jian Han (211805)

“…A non-linear relationship was observed with an inflection point at 7.3. …”

Table_4_Elevated triglyceride-glucose index associated with increased risk of diabetes in non-obese young adults: a longitudinal retrospective cohort study from multiple Asian coun... by Jian Han (211805)

“…A non-linear relationship was observed with an inflection point at 7.3. …”

Effects of bortezomib/venetoclax on the growth suppression of sLCL 381 xenografts in SCID mice. by Kam Pui Tam (19746865)

Lentivirus shRNA knockdown experiment and MTT analysis showing the effect of bortezomib/venetoclax on the cell viability of sLCL 381 and 421 panels. by Kam Pui Tam (19746865)

Raw data of the charts in Fig 5. by Kam Pui Tam (19746865)

“…We postulate that the combination of bortezomib (proteasome inhibitor) and venetoclax (Bcl-2 inhibitor) [bort/venetoclax] will cause synergistic killing of post-transplant lymphoproliferative disorder (PTLD) through targeting the pro-survival function of latent viral proteins such as latent membrane protein-1 (LMP-1) and EBV nuclear antigen-3C (EBNA-3C). …”

Antibodies used in western blot analysis. by Kam Pui Tam (19746865)

“…We postulate that the combination of bortezomib (proteasome inhibitor) and venetoclax (Bcl-2 inhibitor) [bort/venetoclax] will cause synergistic killing of post-transplant lymphoproliferative disorder (PTLD) through targeting the pro-survival function of latent viral proteins such as latent membrane protein-1 (LMP-1) and EBV nuclear antigen-3C (EBNA-3C). …”

Raw data of the charts in Fig 3. by Kam Pui Tam (19746865)

“…We postulate that the combination of bortezomib (proteasome inhibitor) and venetoclax (Bcl-2 inhibitor) [bort/venetoclax] will cause synergistic killing of post-transplant lymphoproliferative disorder (PTLD) through targeting the pro-survival function of latent viral proteins such as latent membrane protein-1 (LMP-1) and EBV nuclear antigen-3C (EBNA-3C). …”